Novartis NOVN -0.09%decrease; down pointing triangle shares rose after the drugmaker reported positive results from two late-stage trials in the most common form of multiple sclerosis, saying its new pill helped patients experience fewer flare-ups.
Shares in Novartis were up 4.5% in European midday trading Tuesday, taking their year-to-date gain to 18%.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8